Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novavax

6.67
-0.4000-5.66%
Post-market: 6.61-0.0600-0.90%19:59 EDT
Volume:13.19M
Turnover:88.19M
Market Cap:1.07B
PE:-5.41
High:7.17
Open:6.99
Low:6.12
Close:7.07
Loading ...

Stock Track | Novavax Shares Plummet 10.40% as FDA Demands New Clinical Trial for Covid-19 Vaccine

Stock Track
·
5 hours ago

Market Chatter: Novavax Asked by FDA to Run Additional Trial on COVID-19 Vaccine

MT Newswires Live
·
4 hours ago

BUZZ-Novavax falls after report FDA demands new trial for COVID vaccine

Reuters
·
5 hours ago

Moderna Shares Lose Ground With Volume Spick in Late Afternoon, Last Down 2%; Pfizer Shares Lose Some Steam, Last up 0.6%

THOMSON REUTERS
·
5 hours ago

FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports

Reuters
·
5 hours ago

Novavax asked for new Covid-19 vaccine trial by FDA, WSJ reports

TIPRANKS
·
5 hours ago

Novavax asked by FDA to complete additional COVID trial, WSJ says

TIPRANKS
·
5 hours ago

Stock Track | Novavax Shares Plummet 10.40% as FDA Demands New Clinical Trial for Delayed Covid-19 Vaccine

Stock Track
·
5 hours ago

BRIEF-FDA Asks Vaccine Maker Novavax To Complete New Clinical Trial For Delayed Covid-19 Shot - WSJ

Reuters
·
5 hours ago

FDA Asks Vaccine Maker Novavax to Complete New Clinical Trial for Delayed Covid-19 Shot - WSJ

THOMSON REUTERS
·
5 hours ago

Novavax Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Yesterday

Stock Track | Novavax Plummets 5% as FDA Delays COVID Vaccine Approval Amid Efficacy Concerns

Stock Track
·
24 Apr

Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?

Zacks
·
24 Apr

Equity Markets Close Higher Over Potential Reduction in US Tariffs on China

MT Newswires Live
·
24 Apr

Novavax Shares Surge 17% as FDA Requests Postmarketing Data for COVID-19 Vaccine

GuruFocus.com
·
24 Apr

Stock Track | Novavax Soars 17% as COVID-19 Vaccine Nears Potential FDA Approval

Stock Track
·
23 Apr

Novavax Shares up 15% After Co Says Covid-19 Vaccine Is Approvable Based on Conversations With the US FDA

THOMSON REUTERS
·
23 Apr

Novavax Says COVID Vaccine Application 'Approvable'

MT Newswires Live
·
23 Apr

FDA Asks Novavax for Commitment on Post-Approval Studies for COVID Vaccine

Reuters
·
23 Apr

BUZZ-Novavax rises after saying its COVID-19 vaccine 'approvable' based on FDA talks

Reuters
·
23 Apr